(Q83191695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Ulrika Kjellström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sten Kjellström

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anitha Bruun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sten Andréasson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Vesna Ponjavic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

Documenta Ophthalmologica

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

35-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16633724%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10633-006-0004-z

19 January 2020

exact match

0 references

cites work

The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms

1 reference

12 December 2020

Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin

1 reference

12 December 2020

No reversion in vigabatrin-associated visual field defects

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin

1 reference

12 December 2020

Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.

1 reference

12 December 2020

Vigabatrin effect on inner retinal function

1 reference

12 December 2020

The legacy of vigabatrin in a regional epilepsy clinic

1 reference

12 December 2020

Standardized full-field electroretinography in rabbits

1 reference

12 December 2020

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

1 reference

12 December 2020

Standard for clinical electroretinography (2004 update).

1 reference

12 December 2020

Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

1 reference

12 December 2020

Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina

1 reference

12 December 2020

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

12 December 2020

Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats

1 reference

12 December 2020

Is visual field constriction in epilepsy patients treated with vigabatrin reversible?

1 reference

12 December 2020

Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss

1 reference

12 December 2020

Recovery of visual field constriction following discontinuation of vigabatrin

1 reference

12 December 2020

Changes in the electroretinogram resulting from discontinuation of vigabatrin in children

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies

1 reference

12 December 2020

Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal

1 reference

12 December 2020

Vigabatrin: longterm follow-up of electrophysiology and visual field examinations

1 reference

12 December 2020

Visual function loss from vigabatrin: effect of stopping the drug

1 reference

12 December 2020

Peripheral retinal dysfunction in patients taking vigabatrin

1 reference

12 December 2020

Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist.

1 reference

12 December 2020

Electro-ophthalmological recovery after withdrawal from vigabatrin

1 reference

12 December 2020